Functional Ultrasound BCIs: Neurovascular Coupling Enters the Interface Debate
A Frontiers review examines functional ultrasound brain-computer interfaces built on neurovascular coupling, surveying progress toward neurological disease applications while the field remains investigational.
Updated
Functional ultrasound (fUS), a technique that images blood-flow changes tied to neural activity, has moved into the brain-computer interface conversation, and a new review in Frontiers maps where it stands. The paper, titled "Applications of functional ultrasound brain-computer interfaces in neurological diseases: research progress based on neurovascular coupling," examines how this vascular readout of brain activity could serve patients with neurological disease.
The review's core premise rests on neurovascular coupling (the mechanism by which local increases in neuronal firing produce corresponding increases in local blood flow). Most bedside brain-computer interfaces read electrical signals directly — scalp EEG (electroencephalography, electrodes placed on the scalp) or intracranial implants. Functional ultrasound takes a different route. It infers neural activity from the hemodynamic response, much as fMRI does, but with portability and resolution that suit longer-term monitoring.
What does the review actually cover?
The authors survey research progress on fUS-based brain-computer interfaces across neurological diseases, organized around the neurovascular-coupling principle that links neural demand to vascular supply. The scope is a research synthesis rather than a single trial. Key threads include:
- How fUS captures regional cerebral blood-volume changes as a proxy for local neural activation
- Candidate neurological applications where decoded vascular signals could drive an interface
- The methodological evidence base built so far, and its gaps
- Comparisons with established electrophysiological approaches such as EEG and ECoG (electrocorticography, electrodes placed directly on the cortical surface)
The Frontiers piece is a review, which carries a practical implication for readers: it synthesizes existing evidence rather than reporting new patient data. No device described in this literature is FDA-cleared for clinical BCI use. Everything in this space remains investigational, and much of the foundational decoding work rests on animal models rather than human cohorts.
Why neurovascular coupling matters for the reading room
For clinical neurophysiologists, the interesting question is what a hemodynamic interface offers that electrophysiology does not. Electrical modalities — scalp EEG, ECoG, intracranial depth recordings — measure neuronal populations directly, at millisecond timescales. Vascular signals lag behind by seconds, because blood flow responds after neurons fire.
The counterweight is spatial information. Functional ultrasound can resolve fine vascular patterns across wide cortical territories, and it does so through a comparatively small cranial window. In an epilepsy monitoring unit, a modality that tracks hemodynamic events alongside scalp EEG could, in principle, add localization context that raw voltage traces omit. The review frames these trade-offs through the lens of neurological disease applications, where chronic, stable signal sources matter as much as speed.
Where does the evidence sit?
The honest answer from the review is that fUS BCIs sit earlier on the translational curve than their electrophysiological counterparts. EEG-based interfaces have run human trials for years. Intracortical arrays have enabled speech and movement decoding in participants with paralysis in separate published studies. Functional ultrasound decoding, by contrast, has demonstrated its core capability mainly in preclinical settings: animals performing tasks while implanted ultrasound probes recorded blood-volume changes tied to intended movement or sensation.
The Frontiers review compiles this progress and asks which neurological populations could eventually benefit. That framing keeps the claims bounded. The paper describes what fUS has demonstrated as a recording method — vascular imaging decoded into control signals under experimental conditions — not what any cleared device currently offers patients.
What should monitoring-unit and lab teams take from it?
Three practical points emerge from the review's framing.
- Modality awareness. Neurovascular signals are a distinct readout class. Teams interpreting combined EEG-plus-hemodynamic datasets will need to understand the timing offsets between electrical events and blood-flow responses.
- Terminology precision. "Functional ultrasound" here means implanted or cranial-window ultrasound imaging of microvasculature, not transcranial Doppler and not focused-ultrasound ablation — modalities that share a word but not a mechanism.
- Regulatory status. Nothing in the reviewed evidence base supports clinical deployment today. The relevant comparison for fUS BCIs is investigational electrophysiological interfaces, which themselves remain largely research tools.
What comes next
The review positions neurovascular coupling as a foundation for the next generation of interfaces in neurological disease: chronic, high-resolution, and potentially less dependent on the electrode-tissue interface that limits implanted electrophysiology over time. Whether fUS decoding reaches human validation at that standard is the open question, and the authors identify it as the field's next hurdle. For now, the Frontiers synthesis gives clinical neurophysiology readers a structured map of where vascular-signal interfaces stand — and a clear marker of how far they still must travel toward the monitoring unit.
Based on
Priya Raman
Show full bio
Market editor covering regulation, policy and their impact on Clinical neurophysiology and EEG interpretation at EEG Signal.